Smead Capital Management 13F holdings, Q4 2013
Holdings as of December 31, 2013 · filings on SEC EDGAR · latest filing →
Smead Capital Management disclosed 29 US equity positions worth $726.1m in its Q4 2013 13F filing. The largest position was Gannett Co Inc Del at 6.9% of the reported book, followed by Cabelas Inc and EBAY. Against the Q3 2013 filing, it opened 1 new position, added to 24 and reduced 3 among the top 29 holdings.
What did Smead Capital Management own in Q4 2013? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2013 |
|---|---|---|---|---|---|---|---|
| 1 | Gannett Co Inc Del | 6.9% | $49.8m | 1,684,682 | 9% | added | |
| 2 | Cabelas Inc | 5.7% | $41.5m | 623,327 | 9% | added | |
| 3 | EBAY Ebay Inc | Consumer Cyclical | 5.7% | $41.1m | 748,646 | 9% | added |
| 4 | Walgreen Company | 5.4% | $38.9m | 677,673 | 9% | added | |
| 5 | DIS Disney Walt Co | Communication Services | 5.0% | $36.4m | 475,809 | 8% | added |
| 6 | A F L A C Inc | 5.0% | $36.0m | 538,448 | 9% | added | |
| 7 | Bank Of America Corp | 4.9% | $35.4m | 2,273,789 | 9% | added | |
| 8 | Amgen Incorporated | 4.7% | $34.2m | 299,539 | 9% | added | |
| 9 | MRK Merck & Co Inc | Healthcare | 4.6% | $33.2m | 662,714 | 41% | added |
| 10 | JPM Jpmorgan Chase & Co | Financial Services | 4.4% | $32.3m | 552,407 | 9% | added |
| 11 | WFC Wells Fargo & Co New | Financial Services | 4.3% | $31.1m | 684,586 | 9% | added |
| 12 | Comcast Cp New Cl A Spl | 3.7% | $26.9m | 539,952 | 9% | added | |
| 13 | Nordstrom Inc | 3.6% | $26.5m | 428,067 | 9% | added | |
| 14 | BEN Franklin Resources Inc | Financial Services | 3.6% | $26.2m | 453,336 | 9% | added |
| 15 | Berkshire Hathaway Cl B | 3.3% | $24.0m | 202,747 | 9% | added | |
| 16 | PFE Pfizer Incorporated | Healthcare | 3.2% | $23.1m | 754,100 | 9% | added |
| 17 | Accenture Ltd Cl A | 3.0% | $22.1m | 268,791 | 9% | added | |
| 18 | Block H & R Incorporated | 3.0% | $21.9m | 754,328 | 9% | added | |
| 19 | HD Home Depot Inc | Consumer Cyclical | 3.0% | $21.6m | 262,388 | 9% | added |
| 20 | Mylan Laboratories Inc | 2.5% | $17.9m | 412,814 | -11% | reduced | |
| 21 | MDT Medtronic Inc | Healthcare | 2.4% | $17.1m | 298,115 | 9% | added |
| 22 | NVR N V R, Inc. | Consumer Cyclical | 2.1% | $15.2m | 14,805 | – | new |
| 23 | ABBV Abbvie Inc | Healthcare | 2.1% | $15.0m | 284,630 | 9% | added |
| 24 | JNJ Johnson & Johnson | Healthcare | 1.8% | $13.4m | 146,458 | 9% | added |
| 25 | MCD Mc Donalds Corp | Consumer Cyclical | 1.7% | $12.3m | 126,816 | 9% | added |
| 26 | Abbott Laboratories | 1.5% | $10.9m | 284,584 | 9% | added | |
| 27 | SBUX Starbucks Corp | Consumer Cyclical | 1.5% | $10.7m | 136,950 | -52% | reduced |
| 28 | BMY Bristol-Myers Squibb Co | Healthcare | 1.4% | $10.3m | 193,483 | -35% | reduced |
| 29 | USB U S Bancorp Del New | Financial Services | 0.2% | $1.1m | 27,571 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.